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The overarching goal of the NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative is to advance the
understanding of healthy and diseased brain circuit function through technological innovation. Core principles for this goal include the
validation and dissemination of the myriad innovative technologies, tools, methods, and resources emerging from BRAIN-funded
research. Innovators, BRAIN funding agencies, and non-Federal partners are working together to develop strategies for making these
products usable, available, and accessible to the scientific community. Here, we describe several early strategies for supporting the
dissemination of BRAIN technologies. We aim to invigorate a dialogue with the neuroscience research and funding community, inter-
disciplinary collaborators, and trainees about the existing and future opportunities for cultivating groundbreaking research products
intomature, integrated, and adaptable research systems. Alongwith the accompanying Society forNeuroscience 2019Mini-Symposium,
“BRAIN Initiative: Cutting-Edge Tools and Resources for the Community,” we spotlight the work of several BRAIN investigator teams
who are making progress toward providing tools, technologies, and services for the neuroscience community. These tools access neural
circuits at multiple levels of analysis, from subcellular composition to brain-wide network connectivity, including the following: inte-
grated systems for EM- and florescence-based connectomics, advances in immunolabeling capabilities, and resources for recording and
analyzing functional connectivity. Investigators describe how the resources they provide to the community will contribute to achieving
the goals of the NIH BRAIN Initiative. Finally, in addition to celebrating the contributions of these BRAIN-funded investigators, the
Mini-Symposium will illustrate the broader diversity of BRAIN Initiative investments in cutting-edge technologies and resources.
Introduction
The Brain Research through Advancing Innovative Neurotech-
nologies (BRAIN) Initiative, now entering its sixth year of fund-
ing, is a collaborative endeavor between federal science funding
agencies and private entities aiming to disentangle the complexity
of the human brain (Mott et al., 2018). To accomplish this goal,
Federal agencies, including the National Institutes of Health
(NIH), have made substantial investments in the development
and optimization of a broad range of innovative technologies and
resources necessary for interrogating the dynamic brain at mul-
tiple spatial and temporal scales and resolutions. At this stage, a
number of new tools have shown promise, and BRAIN invest-
ments are bound to yield many more. However, their scientific
impact depends on their successful dissemination and adoption
by the greater neuroscience community.
Two Working Groups of the Advisory Committee to the NIH
Director (ACD) have provided sage input to guide the BRAIN
Initiative: “BRAIN 2025” for the initial phase and “BRAIN 2.0”
for the second phase. Both emphasize the need to support the
process of moving new tools from the inventors’ benchtops into
laboratories that can use them in their pursuit of important sci-
entific questions. In addition, the Neuroethics Working Group of
the BRAIN Initiative developed a framework (Guiding Princi-
ples) for characterizing and disseminating the neuroethical im-
plications of tools and technologies emerging from the BRAIN
Initiative (Bianchi et al., 2018; Greely et al., 2018). All Working
Groups have emphasized the importance of supporting the dis-
semination and access, commercialization, user training, transla-
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tion, and integration of novel technologies for the use of the
research community.
Initial investments from the NIH, National Science Founda-
tion (NSF), and other BRAIN Initiative partners brought to-
gether engineers, chemists, and material scientists to address
barriers to progress in neuroscience, yielding impressive techno-
logical advances—some funded by the BRAIN Initiative, others
by other Federal or non-Federal sources. In addition to the sev-
eral nearly user-ready tools highlighted in this review, examples
of BRAIN-supported advances include the following: probes for
recording and controlling the activity of neurons and neuronal
ensembles [designer receptor exclusively activated by designer
drugs (DREADDs); Roth, 2016], genetically encoded sensors for
dopamine (Patriarchi et al., 2018; Sun et al., 2018) and calcium
(Qian et al., 2019), advances in single-cell genomic profiling
(drop-sequence; Macosko et al., 2015), microscopy (swept con-
focally aligned planar excitation microscopy; Vaadia et al., 2019),
3-photon microscopy (Yildirim et al., 2019), and human neuro-
imaging (Barandov et al., 2019; Wu et al., 2019). A neural decoder
that converts human cortical activity into speech recently cap-
tured the interest of the scientific community and the public alike
(Anumanchipalli et al., 2019).
Here and in the eponymous Mini-Symposium at the Society
for Neuroscience 2019 meeting in Chicago, we describe several
strategies the NIH has pursued to increase researcher access to the
tools and technologies emerging from BRAIN-funded projects.
We spotlight the work of BRAIN Initiative awardees working to
develop and make available tools that allow the neuroscience
community unprecedented access to knowledge of the brain.
BRAIN Initiative resource access and tool
dissemination: challenges and first steps
The practice of disseminating new research findings is familiar
ground to generations of scholars who have shared their work
with colleagues and the public formally (through publications,
meetings, and presentations) and informally (through collabora-
tions, training, mentorship, and open dialogue). However, tool
development and commercialization present much less familiar
territory for most academic researchers. The scope of scientific
training does not usually include the skills and domain knowledge
necessary for optimization, dissemination, translation, and/or com-
mercialization of innovative technologies. Nor does the academic
incentive structure reward this work. User training, too, often
occurs without formal support. Finally, the best-known funding
mechanisms do not usually support the considerable human or
financial resources and infrastructure needed to move an early
prototype through the demanding stages of development toward
a standardized, robust, end-user-friendly product. Indeed, the
huge range of resource types that BRAIN investigators are gener-
ating (from software to wetware, from basic research tools for use
in animal models to first-in-human devices and accompanying
ethical frameworks) makes a single solution impossible. The
BRAIN Working Group 2.0 considered these challenges in detail,
highlighting early successes and outlining a strategy for devising
new solutions in their June 2019 presentation to the ACD.
Many programs under the umbrella of the NIH BRAIN Ini-
tiative support the initial development and optimization of novel
technologies across seven scientific high-priority areas identified
in the BRAIN 2025 report (National Institutes of Health, 2014).
Recognizing the challenges described above, NIH has initiated
several additional collaborative programs to encourage dissemi-
nation of research tools beyond laboratories of origin. These in-
clude the following.
BRAIN Initiative public–private partnership program for
implantable devices in humans
This program facilitates collaboration between manufacturers of
cutting-edge neuroscience devices and investigators who can use
these in early clinical trials or basic research in human partici-
pants. With advice from the Food and Drug Administration, NIH
has developed template agreements, which have improved re-
searcher access to information about devices not yet available to the
public, and simplified the negotiation process around intellectual
property and publication concerns. Consequently, investigators
can more easily and readily incorporate the most cutting-edge
devices into their research programs, accelerating the translation
of tools and therapies to the market. Information about active
partnerships can be found on the NIH BRAIN Initiative Public-
Private Partnership website.
Small business programs for novel tools and technologies in
neuroscience research
A specific percentage of the NIH extramural budget supports
Small Business Innovation Research (SBIR) and Small Business
Technology Transfer (STTR) grant awards, as required by law 3.2
and 3.65%, respectively. Accordingly, the BRAIN Initiative also
allocates SBIR and STTR funding to support all phases of the
research tool development process, from early development all
the way through to optimization for dissemination and integra-
tion into standard research practices. These programs encourage
collaboration between innovators in academia, and product and
business experts in industry to move technologies to commer-
cialization.
Research resource grants for technology integration
and dissemination
After piloting a small-scope, short-duration NIH-based program
for Technology Sharing and Propagation, NIH has put forth a
more expansive and flexible program to support the gamut of
activities (from tool customization and production to building of
specialized service facilities and user training) beyond the scope
of academic innovation. This research program accounts for stra-
tegic planning, prioritization, and project management. Diverse
types of activities aimed at improving community access to ma-
ture tools and reagents fall under the umbrella of this program,
including reagent and tool validation, iteration, distribution and
production, instrumentation packages, services and facilities,
and end-user training. The associated funding announcement
will continue to accept applications for several more years.
These programs at NIH are part of a broader effort among the
members of the BRAIN Initiative Alliance (BIA) to build infra-
structure for expanding user access to innovative neuroscience
research tools. For example, the NSF contributes to this goal
through the NeuroNex and Brain Observatory programs. Other
efforts at NIH and among the members of the BIA are supporting
new infrastructures for centralizing information about accessing
research tools, complemented by substantial ongoing invest-
ments into resources for data sharing (e.g., https://www.nwb.
org/). The NIH and the BIA both maintain websites that serve as
broad sources of information for the community, compiling re-
sources, funding opportunities, awarded projects, publications,
news, events, and other information relevant to the Initiative. As
the BRAIN Initiative moves forward, these sites will expand to
become portals to the wealth of resources emerging from BRAIN
investments. Less formally, BIA members support the yearly
BRAIN Initiative Investigators Meeting and assorted workshops
that address resource development and dissemination to facili-
8276 • J. Neurosci., October 16, 2019 • 39(42):8275–8284 Litvina et al. • BRAIN Initiative Dissemination
tate collaborations among BRAIN grantees and the broader re-
search community.
Yet, these efforts are only the beginning. Recently, the BRAIN
Working Group 2.0 urged frank, open dialogue with the scientific
community and the public about strategies for dissemination of
novel neurotechnologies and their integration and adoption
throughout the neuroscience research enterprise within a robust
ethical framework. This article and the Mini-Symposium present
an opportunity to begin just such a dialogue.
The remainder of this review describes the work of several
BRAIN Initiative investigator teams contributing to the core
value of technology validation and dissemination. The tools these
investigators plan to share with the community interrogate neu-
ral circuits at different levels of analysis. Some reveal minute
details of subcellular structure and synaptic connectivity pat-
terns, while others capture features of brain network dynamics.
In addition to the tools themselves, these investigators are, im-
portantly, incorporating user training and support into their
plans. In juxtaposing these independent efforts, we take the first
step toward integrating disparate research programs and ap-
proaches into flexible research systems— critical to discovering
“how dynamic patterns of neural activity are transformed into
cognition, emotion, perception, and action in health and disease”
(BRAIN 2025, Goal 7; National Institutes of Health, 2014).
BRAIN Initiative investments in research tool
dissemination
Renewable recombinant miniaturized antibodies for studying
neuronal function (project information)
Antibodies and related affinity reagents have been a key tool for
revealing and integrating knowledge about the brain at the sub-
cellular, synaptic, cellular, and circuit levels. They are widely used
in neuroscience research to label, isolate, and manipulate the
function of specific target molecules in complex experimental
preparations, including in vivo. Using antibodies in multiplexed
immunofluorescence microscopy allows for proteomic-level
analyses of brain cells in diverse species. This includes defining
the neurons that comprise a circuit, the distribution and molec-
ular characteristics of their dendritic and axonal processes, the
physiologically distinct classes of synapses that mediate neu-
rotransmission, and the molecular components of distinct
subcellular compartments. Using antibodies to isolate macromo-
lecular signaling complexes for subsequent proteomic-based
analyses can provide information crucial to determining the spe-
cific molecular events that underlie normal neuronal signaling
and its dysregulation in neurodevelopmental and adult neuro-
logical and psychiatric disorders. Using intracellularly expressed
antibodies (intrabodies) allows the targeting of reporters to spe-
cific sites in neurons to more effectively monitor neuronal func-
tion, and can permit manipulation of normal function or reversal
of dysfunction for experimental or therapeutic purposes (Lo et
al., 2008; Greenfield, 2014; Marschall et al., 2015; Miersch and
Sidhu, 2016).
J.S.T. and colleagues (Gong et al., 2016) have pursued a mul-
tipronged approach to develop, validate, and enhance commu-
nity access to a diverse toolbox of renewable recombinant
antibodies and affinity reagents for neuroscience. First, they have
converted a substantial portion of their existing library of mouse
monoclonal antibodies (mAbs) into recombinant form (An-
drews et al., 2019). This ensures permanent archiving in and
streamlined distribution from plasmid banks and allows for more
reliable expression than conventionally generated mAbs. They
have also engineered mAbs into forms more amenable to multi-
plex labeling applications (Manning et al., 2012), including min-
iaturized single-chain variable fragments (ScFvs; one-sixth the
mass of the intact parent mAb). Second, the group has generated
novel llama nanobodies (nAbs), which are nanoscale antibodies
derived from atypical heavy chain-only antibodies (Dong et al.,
2019). nAbs represent one of the smallest (15 kDa) known
autonomous antigen binding domains. Finally, they have isolated
small (14 –18 kDa) designer proteins of high affinity and spec-
ificity, called designed ankyrin repeat proteins (DARPins), from
highly diverse combinatorial libraries (Plu¨ckthun, 2015). Figure
1 illustrates these three classes of affinity reagents and examples of
their use in neurons. Overall, the small size, solubility, and stabil-
ity of ScFvs, nAbs and DARPins facilitate their functional expres-
sion in mammalian cells, allowing for their use as intrabodies
(Staus et al., 2016; Guillard et al., 2017). Their small size also
enhances the resolution of imaging obtained when they are used
as immunolabels (Beghein and Gettemans, 2017; Traenkle and
Rothbauer, 2017), and enhances their penetration into tissue,
cells, and subcellular compartments, allowing for integration
with correlative microscopy and whole-brain imaging ap-
proaches (Fang et al., 2018; Yamagata and Sanes, 2018). Similarly,
miniaturized nanoscale immunolabeling reagents permit higher-
resolution imaging of the molecular anatomy of neurons at the
ultrastructural (immunogold-EM) and super-resolution scales.
Working with a consortium of experts in multiple imaging
applications, this team will ultimately provide to the community
a validated set of recombinant immunolabeling reagents that can
be readily deployed with precision for high-resolution mapping
of the components and structure of neural circuits. These re-
agents, in concert with the services of the connectomics facility
described next, can enrich the resulting dataset with information
about experimentally relevant molecular components of the neu-
ral circuit.
A facility to generate connectomic information (project
information)
Connectomics is a nascent field of neuroscience aiming to pro-
vide a pathway for investigators to obtain complete descriptions
of the brain circuits they study at synaptic resolution. Despite
widespread interest in dissecting neural circuits, such descrip-
tions have been nearly impossible to come by until recently due to
multiple technical obstacles, not least of which is the challenge of
bringing together the diverse expertise required to transform a
volume of brain tissue into a densely annotated computational
representation of the underlying neural circuits.
J.W.L. and colleagues (Morgan and Lichtman 2017) have been
working to overcome these technical challenges to make connec-
tomics a routine, accessible analytical tool for the community.
They are developing a partially automated pipeline that begins
with a three-dimensional sample of brain tissue and ends with a
“digital tissue.” These digital tissues are volumetric datasets that
contain all the histological elements in the brain sample including
each nerve cell process and all the interconnecting synapses.
Figure 2 illustrates the overall process. They prepare a nervous
system sample for electron microscopy, examine it with micro-
computerized tomography to evaluate the stain quality, generate
ultrathin (typically 30 nm) sections with a diamond knife ul-
tramicrotome, pick up the sections on a tape using the ATUM
(automatic tape-collecting ultra-microtome) method, put the
tape as strips on silicon wafers, map the position of each section
with optical microscopy (Hayworth et al., 2014), and automati-
cally image the sections with scanning electron microscopy.
Computational tools help stitch and align the sections. A
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computer-assisted tracing program (VAST;
Berger et al., 2018) annotates and seg-
ments the neural circuitry data, which can
then be used to obtain the wiring diagram,
and then finally analyze the results. These
data are also used as ground truth for
machine-learning classifiers of neuro-
nal processes and synapses using convo-
lutional neural nets (Kasthuri et al.,
2015; Morgan et al. 2016).
The group is developing ways to adapt
or augment this pipeline for diverse ex-
perimental needs. For example, it is possi-
ble to implement correlated light and
electron microscopy of the same samples
using nanobody probes that allow molec-
ular identification of cell types or other
details without adversely affecting the
quality of the ultrastructure (Fang et al.,
2018). Breakthroughs in machine-learning
tools for image segmentation, synapse
identification, stitching, and alignment
have made it possible to consider very
large volumes and perhaps whole nervous
systems in a range of species. With larger
species and larger brains, however, the
rate-limiting step becomes the speed of
image acquisition. Multibeam electron
microscopes that parallelize image acqui-
sition can be incorporated into the pipe-
line to address this issue (Eberle et al.,
2015). Lichtman and colleagues will pro-
vide training and guidance along with
access to state-of-the-art facilities and
technologies required to provide an inves-
tigator without expertise in the technical
aspects of connectomics with a complete
dataset and the means to interpret it.
Understanding synapses in the brain
through three-dimensional electron
microscopy (project information)
High-throughput electron microscopy can also be used to inter-
rogate the subcellular structures that support synaptic function.
Neuroscience has not yet characterized the variability of synaptic
dimensions, connectivity, or subcellular content across cell types,
brain regions, species, and taxa. Without this information, it is
difficult to evaluate the adequacy of model systems for approxi-
mating the biology and function of the human brain. Current
approaches to characterizing synaptic structure are limited by
resolution, inefficient and insufficient data collection, and anal-
ysis bottlenecks, which limit the uptake and dissemination of data
and its utility for building knowledge.
As part of the NeuroNex Technology Hub, K.M.H. and col-
leagues are collaborating with scientists and cyberinfrastructure
experts at the University of Texas-Austin, the Salk Institute for
Biological Studies, and the Texas Advanced Computing Center to
address these limitations.
First, they are enhancing three-dimensional electron micros-
copy (3DEM) capabilities. Automated image collection on the
scanning electron microscope operating in the transmission
mode (tSEM) provides in-plane image resolution of 1 nm for
large fields (2500 m 2) with minimal distortion and no mon-
taging. When collected across serial sections, the image volumes
are large enough to quantify synapses in local circuits while main-
taining the nanoscale resolution needed to assess the function of
subcellular components, local axons, and perisynaptic astroglia
(Fig. 3, example image). Obliquely cut membranes can obscure
functionally significant components of synapses, including extra-
cellular space, nascent synaptic zones, smooth endoplasmic retic-
ulum and spine apparatus, perisynaptic astroglia, filopodia, and
local axon trajectories. K.M.H. and colleagues are addressing this
issue by enhancing depth-dependent discrimination of mem-
brane borders through improving axial resolution using conical
tilt tomography combined with tSEM in thick (250 nm) serial
sections. The resulting tomogram can be used to calculate virtual
thin sections (15 nm) while maintaining in-plane resolution
(2 nm). The enhanced resolution will increase data volume
while streamlining image processing by producing more isotro-
pic image volumes.
Second, the team is confronting the challenge of increasing
data volume by integrating software tools to enhance registra-
tion, reconstruction, editing, and analysis of synaptic neuropil.
They are building upon publicly available registration, tracing,
and segmentation software (e.g., Reconstruct, SWiFT-IR, TrakEM2
Figure1. Renewable affinity reagent resources andapplications. To the left are schematics of thedifferent classes of renewable
affinity reagentsdevelopedby J.S.T. and colleagues (adapted fromHelmaet al., 2015). The right columnshowsexamplesof images
obtained using nAbs as intrabodies or immunolabels (adapted from Dong et al., 2019). The top shows a cultured rat hippocampal
neuron 9 d after infection with lentivirus encoding a YFP-tagged anti-Homer1 nAb (green) and immunolabeled for Homer1 in red
and MAP2 (microtubule associated protein 2) in blue. Note the lack of accumulation of nAb in the soma (*) and its robust
localization in dendrites. The middle panels show high-magnification images of two different (HC20 and HC87) YFP-tagged
anti-Homer1 nAbs (green) and Homer1 immunolabeling (red) from a similar experiment, demonstrating the specificity of both
intracellularly expressednAbsby their specific accumulation at synapses. Thebottompanel shows thehippocampal region froman
adult rat brain section immunolabeled with an anti-Homer1 nAb (green) and an anti-Homer1 mAb (magenta). HcAb Heavy
chain antibodies.
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and FIJI, IMOD, Flood-Filling Networks, Neuroglancer, and
others) along with model building software (e.g., MCell, Neuro-
Morph, and Neuropil) to enhance analysis of the image data and
subcellular modeling.
Finally, the team is building a data depot for 3DEM datasets.
An on-line 3DEM Hub will host a knowledge discovery work-
space for 3DEM software tools and automated workflows, and a
learning center for tutorials and virtual workshops, built upon
state-of-the-art high-performance computing resources.
Altogether, this work will allow the community to improve un-
derstanding of synapse structure, connectivity, and function across
brain regions and species while making vast improvements in quan-
titative analysis of high-resolution neuronal structure data.
High-throughput, quantitative connectomics using
fluorescence microscopy (project information)
High-resolution volumetric reconstructions of EM data de-
scribed above enable a detailed exploration of synapse orga-
nization and connectivity. However, these methods cannot
comprehensively label specific cell types, and only reveal connec-
tivity within a specified volume of tissue. Moreover, volumetric
EM analysis is not typically accessible to individual investigators
without specialized facilities and dedicated image-processing re-
sources. In contrast, fluorescence-based synapse detection is well
suited for broad adoption by the neuroscience community in
diverse experimental preparations. Although immunohisto-
chemical approaches provide comprehensive coverage of tissue
samples (i.e., all synapses of a given type can be detected), dense
labeling can make it difficult to correctly assign synapses to spe-
cific presynaptic and postsynaptic partners, a key parameter in
defining and quantitating circuit-specific alterations in brain
function. Genetically encoded, fluorescent synaptic tags with cell
type-specific expression provide an alternate method for synapse
identification and volumetric analysis. Fluorescence-based mo-
lecular genetic methods take advantage of widely used transgenic
mouse lines and fluorophores to facilitate accurate and auto-
mated analysis of large numbers of cells across many experimen-
tal conditions (Chen et al., 2012; Gross et al., 2013; Druckmann et
al., 2014; Fortin et al., 2014; Choi et al., 2018). Sparse labeling of
neurons allows unambiguous isolation of presynaptic and post-
synaptic elements. In addition, multispectral labeling in brain
tissue can help visualize the three-dimensional organization of
synapses and glia, revealing principles of complex, multisynapse,
and glial organization.
To meet the challenge of quantitative synaptic analysis, several
teams have developed virally delivered molecular genetic re-
agents for pansynaptic fluorescent labeling of postsynaptic sites
that can be used in conjunction with presynaptic cell fills to detect
Figure 2. A partially automated electron microscopy connectomics pipeline. This schematic outlines the steps of the partially automated pipeline, from live imaging and sample fixation and
sample fixation through to data output and analysis.
Figure 3. 3DEM provides high-resolution synaptic structure data. High-resolution serial EM
reconstruction of a dendrite with its spines (beige), axons (light blue) that form synapses (red)
on the dendrite, and the internal mitochondrion (green) and smooth endoplasmic reticulum
(yellow).
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and quantitate specific synapse types and
to align presynaptic and postsynaptic
neurites in complex brain structures.
These reagents include modular presyn-
aptic and postsynaptic approaches like
mGRASP (mammalian/enhanced GFP
reconstitution across synaptic partners,
Kim et al., 2011; Choi et al., 2018), fluo-
rescently tagged synaptic scaffolding mol-
ecules such as PSD-95 and gephyrin
(Chen et al., 2012; Fortin et al., 2014), and
fibronectin-repeat intrabodies (Gross et
al., 2013).
A.B., M.B., and colleagues have adapted
a neuroligin-1-based transmembrane and
cytoplasmic domain for synapse targeting,
incorporating an extracellular fluores-
cence tag using either the fluorogen-
activating protein (FAP; Szent-Gyorgyi et
al., 2008) or yellow fluorescent protein
(YFP) combined with a cell-filling dTo-
mato fluorophore for alignment with pre-
synaptic neurites (FAPpost or YFPpost;
Fig. 4). Virus-mediated expression of FA-
Ppost yields punctate labeling across the
somatodendritic arbor of diverse neuro-
nal subtypes, allowing for quantitation of specific inputs across a
single postsynaptic neuron using commercially available image
analysis software (Imaris). Immunostaining with synaptic mark-
ers shows that FAPpost puncta localize to both inhibitory and
excitatory synapse types. Importantly, the expression of FAPpost
does not alter the frequency or amplitude of miniature excitatory
or inhibitory currents in neurons, suggesting that it does not
drive abnormal synapse stabilization that may be a problem for
mGRASP- or PSD-95-conjugated fluorophores (El-Husseini et
al., 2000; Gross et al., 2013). Pyramidal neuron expression of
FAPpost, combined with labeling of inhibitory neurons with Cre
transgenic reporter lines, are revealing unexpected localization
patterns of inhibitory inputs and how they change during exper-
imental manipulations. In addition to developing, validating,
and making available this molecular toolkit (catalog #105981,
#105982, #105983, Addgene), the team is building a high-
throughput analysis pipeline for the quantitative florescence-
based detection of putative synapses, laying the groundwork for
large-scale analysis of learning- and disease-dependent synaptic
reorganization. Investigators at Carnegie Mellon and the Uni-
versity of Pittsburgh, in collaboration with the Pittsburgh Su-
percomputing Center, have established a data-sharing resource
for brain-scale confocal microscopy datasets to enable robust and
reliable data sharing and integration of the massive datasets gen-
erated by these and other tools supported by the BRAIN Initiative
(e.g., in the BRAIN Initiative Cell Census Network).
New tools for understanding distributed patterns of brain
activity (project information)
The methodological advances described so far primarily concern
structural analysis of fixed brain tissue. Many BRAIN Initiative
investigators, including the remaining two teams to be discussed,
are working to advance the study of the dynamics of the living
brain.
The brain is a massively interconnected network of specialized
circuits. Even primary sensory areas, once thought to support
relatively simple, feedforward processing, are now known to par-
ticipate in complex feedback loops. Two characteristics of a brain
network make its study particularly challenging. First, its dynam-
ics have a range of relevant timescales: sensory processing and
decision-making can occur in milliseconds, but changes in activ-
ity patterns that support adaptation, learning, and related func-
tions occur over the lifetime, on timescales ranging from seconds
to years. Second, the network spans spatial scales: circuits consist
not only of nearby neurons, but also of neurons distributed
across multiple, distant brain areas.
In collaboration with the Neurotechnology Group at Law-
rence Livermore National Laboratory, L.M.F. and colleagues
designed and fabricated high-density, multichannel polymer re-
cording arrays (LL-FL probes) to address these challenges. These
are flexible and biocompatible devices that can be inserted into
the brain surgically using a removable silicon shuttle (Felix et al.,
2013). For chronic recordings, a multiprobe implant can stabilize
and protect the devices to yield long-term, high-density distrib-
uted recordings in freely moving rats (Chung et al., 2019b; Fig. 5).
More recently, the team has refined the insertion technique, in-
corporating 3D sharpened shuttles (Joo et al., 2019), which re-
duce the force required for insertion and can penetrate dura.
These tools allow access to multiple relevant temporal and
spatial scales. First, at millisecond timescale resolution, they yield
high-quality single units recorded continuously over many
months. Recording continuously for 10 –11 d in three animals
(Chung et al., 2019a), the team tracked the activity of 2232 units
from rat medial prefrontal cortex (mPFC), each for at least 24 h.
Of the 1150 units first detected in the initial few days of the 10 –11
d period, 21% (247 of 1150) could be followed for 1 week.
Second, these probes and the associated hardware and software
(Chung et al., 2017) permit high-density sampling from multiple
brain regions. To illustrate the potential for high-channel count
recordings, the team recorded from eight 64-channel devices dis-
tributed across the following three brain areas: mPFC, orbito-
frontal cortex, and ventral striatum. This yielded 375 well isolated
single neurons across the three brain regions. Two devices opti-
mized for local field potential recording were also implanted in
dTom FAPpost
dTom FAPpost PV
PV NonPV
PV NonPV
PV NonPV
DCO4_CA1_Pyr_3 
A
B
C
D
E
Figure 4. High-throughput fluorescence-based detection and assignment of synaptic inputs using genetically encoded synap-
tic markers. A, Example dendritic segment from dtomato-filled CA1 pyramidal neuron postsynaptically labeled with FAPpost
(pseudo-colored green). Scale bar, 2 m. B, As in A but showing immunohistochemically labeled parvalbumin (PV) neurites
(pseudo-colored pink). C, High-threshold surface rendering of postsynaptic puncta (green), with PV-associated puncta in red. D,
Schematic of individual puncta rendered as spots. E, Example neuron with assigned PV puncta. Scale bar, 10m.
8280 • J. Neurosci., October 16, 2019 • 39(42):8275–8284 Litvina et al. • BRAIN Initiative Dissemination
hippocampus, allowing the identification of hippocampal sharp-
wave ripple (SWR) events. Although SWRs are known to modu-
late firing rates in regions including mPFC (Joo and Frank, 2018),
it is unknown whether the same SWR events engage coordinated
patterns of activity across areas simultaneously. Having elec-
trodes distributed across multiple regions permitted comparing
responses in these regions to the same hippocampal events to
address this question, which has implications for our under-
standing of memory processes. This would not have been possi-
ble without the combination of high-density recordings in
individual regions and the ability to distribute those recordings
across brain regions. Thus, these tools make it possible to ask new
questions about how the brain changes over time and how brain
regions interact to process information. The probes and associ-
ated software are being developed for dissemination to the com-
munity, and the team has started to collaborate with prospective
early adopters, providing refined devices as well as training in
device handling and surgical implantation through on-site visits
and video conferences.
Group iterative multiple model estimation: a tool for
multiscale model selection and unsupervised classification
(project information)
Understanding relationships of activity within and across multi-
ple brain regions and neural systems is an even greater challenge
in human neuroscience. Network methods for the analysis of
functional MRI data have proven fruitful with the current state of
science dictating that the brain is best understood as coordinated
activity across spatially disparate regions. However, a gap in com-
putational methods exists for quantifying these relations. The
following two primary computational problems exist: (1) quan-
tifying person-specific estimates for how each brain region in a
given brain network relates to overall network activity (i.e., how
integral to the network is that region for that individual?); and (2)
identifying consistent patterns of estimates that may exist—
within and between brain networks—amid the heterogeneity in
brain processes seen among human individuals. K.M.G. and col-
leagues are introducing a set of tools that build from group iter-
ative multiple model estimation (GIMME; Gates and Molenaar,
2012), a model search procedure that reliably recovers sparse
patterns of relations among brain areas in functional MRI data
collected during the resting state and during task performance.
The two primary developments are as follows: latent variable
GIMME (LV-GIMME; Gates et al., 2019) and subgrouping
GIMME (S-GIMME; Gates et al., 2017). Both are freely available
within the R package gimme (Lane et al., 2019) with documenta-
tion available on-line (http://gimme.web.unc.edu/63-2/). The
group has validated and freely distributed these statistical tools
and software and will make the simulated and empirical valida-
tion data available once the initial papers have been accepted for
publication. This will enable the community to interrogate the
interactions within and between brain networks—across multi-
ple sensory systems, internal states, and cognitive regions—that
drive human behavior.
LV-GIMME enables the examination of brain processes as
they occur across multiple spatial resolutions, allowing research-
ers to simultaneously investigate research questions at the voxel,
region, and network levels. Numerous options for analyzing net-
work activity are available, including principal component anal-
ysis and varied methods of factor analysis estimation. However,
few existing methods take into account the known temporal de-
pendencies in fMRI data (i.e., that activity at a prior time point
can predict activity at a later time point). LV-GIMME uses a
method that appropriately accounts for these dependencies by
using a dynamic factor-analytic framework as well as an estima-
tion procedure that is optimal for use with time series data (Fisher
et al., 2019). The estimation approach, called model implied in-
strumental variable estimation (Bollen, 1996) is well established
and has been shown by K.M.G. and colleagues to provide robust
estimates even in the presence of model misspecifications that are
likely to occur in fMRI data analysis (Bollen et al., 2018). Figure 6
depicts the dynamic factor model approach with relations among
brain networks as well as relations capturing the extent to which
specific brain regions (or voxels) relate to others within a given
network.
During the model-building process, users can use unsuper-
vised classification with S-GIMME to parse out subsets of indi-
viduals, identifying those who have similar brain processes. This
Figure 5. Long-lasting, high-quality recordings from polymer probes. Each main panel illustrates the recordings obtained on 1, 45, 154, or 283 d after implantation. Each subpanel shows the
waveforms (mean SD) of a putative single neuron across the two to four electrode contacts onwhich that waveformwas of highest amplitude. The geometry of the contacts relative to the probe
is shown in the center of eachmain panel, and the colored bars indicate the specific electrode contacts. These recordings were taken from one 18-channel shank of a two-shank probe and illustrate
that high-quality recordings can be obtained for many months.
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method addresses unaccounted-for heterogeneity across individ-
uals, which can decrease the statistical reliability of results from
most commonly used methods of analysis, impacting replicabil-
ity (Molenaar, 2004; Smith, 2012). The unsupervised classifica-
tion method appropriately classified individuals according to the
task they were conducting at multiple levels of spatial resolution.
It must be stressed that this robust classification occurred using
solely the brain time courses (i.e., variation in the BOLD signal
across time) with no information provided regarding tasks or the
individuals. This tool has already been used to classify individuals
within predefined categories (Price et al., 2017a; McCormick et
al., 2019), as well as identify differences in functional connectivity
between typically developing controls and diagnostic categories
(Price et al., 2017b; Henry et al., 2019).
These tools offer researchers an easy-to-use method for quan-
tifying brain functional connectivity in new and robust ways.
These novel methods are providing the scientific community
with the means to achieve the audacious goals of the BRAIN
Initiative, allowing us to peer into the human brain in action and
expand our capacity to understand the diversity of brain pheno-
types. As we develop new technologies, such as those that enable
the classification of individuals based on readouts of their neural
circuit activity, comes a responsibility to consider their medical
and social implications becomes paramount. Neuroscientists en-
gaging with neuroethicists can most effectively promote their
responsible application and translation (Rommelfanger et al.,
2018).
In conclusion, examples above represent only a small fraction
of the constantly growing collection of BRAIN Initiative-
supported innovations with applications that stretch from the
most basic science to clinical diagnosis and treatment applica-
tions. A major goal of the next phase of BRAIN must be to enable
access to these technologies through creative new mechanisms.
The process of transforming a tool used by a single researcher
into a turnkey device that can be deployed to any laboratory has
been the purview of industry. NIH incentivizes this type of devel-
opment toward commercialization through its small business
grant mechanisms, connects academic users to next-generation
devices through the BRAIN Initiative Public-Private Partnership
program, and provides resources for alternative dissemination
models through the BRAIN Initiative research resource grant
program. In addition to encouraging tool development and the
establishment of an infrastructure for disseminating them, the
BRAIN Initiative supports the training of investigators in the
skillful use of these sophisticated tools.
Analysis of the vast arrays of data produced by BRAIN Initia-
tive teams also requires new computational and collaborative
tools. Recognizing that expanding the technical toolbox for neu-
roscience will both require and drive a proliferation of novel
datasets, the NIH has developed a new policy to encourage the
Figure6. LV-GIMMEenables simultaneous quantification and examination of functional activity acrossmultiple layers of spatial resolution. This figure depicts the dynamic relations amongbrain
networks aswell as relations among brain regions (or voxels)within a given network. “Contemporaneous” refers to relations between networks at a lag of zero; “lagged” refers to relations between
networks at a lag of 1; “parameter” refers to the fact that between-network relations can be interpreted as regression coefficients, whereas for thewithin-network activity the parameters represent
the degree towhich a given brain region or voxel relates to other brain regions in a predefined brain network. Population is the simulated value and estimate is the average estimate obtained across
a small simulation study.
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preservation, sharing, and secondary analysis of data collected as
part of BRAIN Initiative-funded projects. The policy requires
BRAIN investigators to develop and implement data sharing
plans using an infrastructure built and supported through the
BRAIN Initiative as well. Continued investment into expanding
access to novel tools, resources, and datasets, alongside greater
support for efforts to integrate existing resources into flexible
research systems, will pave the road toward greater fundamental
insights into the workings of the human brain and transform the
study, treatment, cure, and prevention of brain disorders.
The variety of tools we have described illuminate the key to the
success of the BRAIN Initiative and of neuroscience as a field—an
interdisciplinary outlook, in the broadest meaning of the con-
cept. Critical to the continued success of this grand project are the
many efforts that cultivate this interdisciplinarity: programs and
commitment to expand and enhance training for emerging sci-
entists, facilitate collaboration with experts across a wide swath of
the sciences, enable data sharing and promote scientific integrity
and rigor, support a diversity of voices in neuroscience, and in-
tegrate neuroethical considerations to ensure that neurotechno-
logical innovation, development, and dissemination proceed in
scientifically and ethically relevant and responsible directions.
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